Imatinib - CaLiGraph

Property	Value
rdf:type	World Health Organization essential medicine owl:NamedIndividual Cancer treatment Disease Novartis brand Orphan drug Piperazine Pyridine Aminopyrimidine Largest selling pharmaceutical product Antileukemic drug Benzanilide Antineoplastic agent Chemotherapeutic agent Non-receptor tyrosine kinase inhibitor
rdfs:label	Imatinib
owl:sameAs	dbr:Imatinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/List_of_largest_selling_pharmaceutical_products http://en.wikipedia.org/wiki/Category:Aminopyrimidines http://en.wikipedia.org/wiki/Eosinophil http://en.wikipedia.org/wiki/Receptor_tyrosine_kinase http://en.wikipedia.org/wiki/List_of_antileukemic_drugs http://en.wikipedia.org/wiki/Scleroderma http://en.wikipedia.org/wiki/Targeted_therapy http://en.wikipedia.org/wiki/Category:Non-receptor_tyrosine_kinase_inhibitors http://en.wikipedia.org/wiki/Category:Cancer_treatments http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Piperazines http://en.wikipedia.org/wiki/Category:Pyridines http://en.wikipedia.org/wiki/List_of_drugs:_Im%E2%80%93In http://en.wikipedia.org/wiki/List_of_antineoplastic_agents http://en.wikipedia.org/wiki/List_of_chemotherapeutic_agents http://en.wikipedia.org/wiki/Nanjing_Ange_Pharmaceutical http://en.wikipedia.org/wiki/Dasatinib http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines_for_Children http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/Hypopigmentation http://en.wikipedia.org/wiki/Category:Novartis_brands http://en.wikipedia.org/wiki/Novartis http://en.wikipedia.org/wiki/Benzylpiperazine http://en.wikipedia.org/wiki/Grapefruit%E2%80%93drug_interactions http://en.wikipedia.org/wiki/Category:Benzanilides http://en.wikipedia.org/wiki/CYP3A4 http://en.wikipedia.org/wiki/Mastocytosis http://en.wikipedia.org/wiki/Timeline_of_cancer_treatment_development http://en.wikipedia.org/wiki/Piperazine http://en.wikipedia.org/wiki/Dana%E2%80%93Farber_Cancer_Institute http://en.wikipedia.org/wiki/Personalized_medicine
skos:prefLabel	Imatinib
skos:altLabel	diseases Gleevec Gleevec (Imatinib) Glivec Imantinib Imatinib mesylate STI571 imatinib imatinib mesylate imatinib therapy
clgo:alternativeName	Gleevec, Glivec, others
clgo:bioavailability	98.0
clgo:casNumber	(mesilate) 152459-95-5
clgo:chEBI	45783
clgo:chEMBL	941
clgo:class	Tyrosine kinase inhibitor
clgo:drugbank	DB00619
clgo:fdaUniiCode	BKJ8M8G5HI
clgo:kegg	D08066
clgo:medlinePlus	a606018
clgo:pubchem	5291
is clgo:knownFor of	Nicholas Lydon Brian Druker

About: clgr:Imatinib